文献速递糖尿病肥胖与代谢综合征

美国2型糖尿病患者中晚期肝纤维化患病率高:瞬时弹性成像评估

High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2020-12-10

基于2017-2018年美国国家健康与营养调查的横断面研究,纳入825例接受瞬时弹性成像的2型糖尿病成人,评估肝脂肪变和纤维化患病率及相关因素。结果显示肝脂肪变患病率73.8%,晚期纤维化15.4%,肝硬化7.7%,肥胖是主要风险因素。

要点

  • 2型糖尿病成人中肝脂肪变患病率高达73.8%,晚期纤维化15.4%。
  • BMI、非黑人种族、ALT是肝脂肪变的独立预测因素。
  • BMI、非黑人种族、AST和GGT是晚期纤维化的独立预测因素。

核心结论

  • 美国2型糖尿病患者中肝脂肪变和纤维化患病率均较高,肥胖是主要风险因素,结果支持对糖尿病患者进行筛查。

研究设计与样本

  • 横断面研究,纳入2017-2018年美国国家健康与营养调查中接受瞬时弹性成像的2型糖尿病成人825例,其中484例(53.7%)使用M探头,341例(46.3%)使用XL探头。

主要发现

  • 肝脂肪变(CAP ≥274 dB/m)患病率为73.8%(95% CI 68.5%-78.5%)。
  • 晚期纤维化(LSM ≥9.7 kPa)患病率为15.4%(95% CI 12.2%-19.0%)。
  • 肝硬化(LSM ≥13.6 kPa)患病率为7.7%(95% CI 4.8%-11.9%)。
  • 晚期纤维化患者平均年龄63.7 ± 2.2岁,肝硬化患者平均年龄57.8 ± 1.6岁。
  • 多变量逻辑回归中,BMI、非黑人种族和ALT水平是肝脂肪变的独立预测因素;BMI、非黑人种族、AST和γ-谷氨酰转肽酶水平是晚期纤维化的独立预测因素。

关键数值与推荐

  • 肝脂肪变定义为CAP ≥274 dB/m。
  • 晚期纤维化定义为LSM ≥9.7 kPa。
  • 肝硬化定义为LSM ≥13.6 kPa。

临床怎么用

  • 对2型糖尿病患者应考虑筛查肝脂肪变和晚期纤维化,尤其关注肥胖患者。

局限性

  • 横断面设计无法推断因果关系。
  • 仅纳入具有可靠瞬时弹性成像结果的参与者,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type 2 diabetes mellitus (T2DM) is an important risk factor for the progression of metabolic liver disease to advanced fibrosis. Here, we provide an estimate of the prevalence of steatosis and fibrosis in U.S. adults with T2DM on the basis of transient elastography (TE) and identify factors associated with these conditions. RESEARCH DESIGN AND METHODS: This is a cross-sectional study of U.S. adults with T2DM participating in the 2017-2018 cycle of the National Health and Nutrition Examination Survey who were evaluated by TE. Hepatic steatosis and fibrosis were diagnosed by the median value of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), respectively. RESULTS: Among the 825 patients with reliable TE examination results, 484 (53.7%) were assessed using the M probe and 341 (46.3%) using the XL probe. Liver steatosis (CAP ≥274 dB/m), advanced fibrosis (LSM ≥9.7 kPa), and cirrhosis (LSM ≥13.6 kPa) were present in 73.8% (95% CI 68.5%-78.5%), 15.4% (95% CI 12.2%-19.0%), and 7.7% (95% CI 4.8%-11.9%) of patients, respectively. The mean ± SE age of patients with advanced fibrosis and cirrhosis was 63.7 ± 2.2 years and 57.8 ± 1.6 years, respectively. In the multivariable logistic regression model, BMI, non-Black race, and ALT levels were independent predictors of steatosis; and BMI, non-Black race, and AST and γ-glutamyltranspeptidase levels were independent predictors of advanced fibrosis. CONCLUSIONS: Prevalence of both liver steatosis and fibrosis is high in patients with T2DM from the United States and obesity is a major risk factor. Our results support the screening of these conditions among patients with diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ciardullo S, Monti T, Perseghin G, et al. High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes. Diabetes Care. 2020. PMID: 33303638. doi:10.2337/dc20-1778

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。